Skip Navigation Genome.gov - National Human Genome Research InstituteGenome.gov - National Human Genome Research InstituteGenome.gov - National Human Genome Research InstituteNational Institutes of Health
   
       Home | About NHGRI | Newsroom | Staff
Research Grants Health Policy & Ethics Educational Resources Careers & Training

Home>About NHGRI>About the Office of the Director>Reports and Workshop Summaries from OD>New Directions for Sickle Cell Therapy in the Genome Era >Conference Agenda

New Directions for Sickle Cell Therapy in the Genome Era

Agenda

Wednesday, November 19, 2003
8:30-9:00 a.m. Welcome: Drs. Zerhouni, Collins, Alving and Weatherall
Moderator: Greg Evans
9:00-9:30 a.m. Plenary I: The Pathophysiology of Sickle Cell Disease: State of the Art - Martin Steinberg
9:30-9:50 a.m. Discussion
9:50-10:20 a.m. Break
10:20-10:50 a.m. Plenary II: Therapeutics for Sickle Cell Disease: State of the Art - Elliott Vichinsky
10:50-11:10 a.m. Discussion
11:10-11:40 a.m. Plenary III:  Therapeutic Implications of Phenotypic Diversity - Orah Platt
11:40-12:00 p.m. Discussion
12:00-1:00 p.m. Lunch
Moderator: Karen Hofman
1:00-1:30 p.m. Plenary IV: Hemoglobin Switching - George Stamatoyannopoulos
1:30-1:50 p.m. Discussion
1:50-2:20 p.m. Plenary V: Gene Transfer - Michel Sadelain
2:20-2:40 p.m. Discussion
2:40-3:00 p.m. Break
3:00-3:30 p.m. Plenary VI: Small Molecule/Chemical Genomics Approaches - John Haley
3:30-3:50 p.m. Discussion
3:50-4:20 p.m. Plenary VII: Historical, Cultural, and Social Context of Clinical Research in Sickle Cell Disease - Vanessa Northington Gamble
4:20-4:40 p.m. Discussion
4:40-5:00 p.m. Instructions to Working Groups - Alan Guttmacher
5:00-6:00 p.m.

 Reception
Thursday, November 20, 2003
8:30-10:00 p.m. Concurrent Working Groups- Session A
  • Therapeutic Implications of Phenotypic Diversity - Kwaku Ohene-Frempong
  • Hemoglobin Switching - Susan Perrine
  • Gene Transfer - Punam Malik
  • Small Molecule/Chemical Genomics Approaches - Christopher Austin
  • Historical, Cultural, and Social Context of Clinical Research - Lennette Benjamin
10:00-10:30 p.m. Break
10:30-12:00 p.m. Concurrent Working Groups - Session A (Continued)
12:00-1:00 p.m. Lunch
1:00-2:30 p.m. Concurrent Working Groups - Session B
  • Therapeutic Implications of Phenotypic Diversity - Swee-Lay Thein
  • Hemoglobin Switching - George Dover
  • Gene Transfer - David Bodine
  • Small Molecule/Chemical Genomics Approaches - Alan Schechter
  • Historical, Cultural, and Social Context of Clinical Research - Joseph Telfair
2:30-3:00 p.m. Break
3:00-4:30 p.m. Concurrent Working Groups - Session B (Continued)
7:00-9:30 p.m.

 Group Dinner - Remarks by Sir David Weatherall
Friday, November 21, 2003
Moderator: Alan Guttmacher
8:00-8:30 a.m. Presentation/Discussion - Working Groups on Therapeutic Implications of Phenotypic Diversity
8:30-9:00 a.m. Presentation/Discussion - Working Groups on Hemoglobin Switching
9:00-9:30 a.m. Presentation/Discussion - Working Groups on Gene Transfer
9:30-10:00 a.m. Presentation/Discussion - Working Groups on Small Molecule/Chemical Genomics Approaches
10:00-10:30 a.m. Break
10:30-11:00 a.m. Presentation/Discussion - Working Groups on Historical, Cultural and Social Context of Clinical Research in Sickle Cell Disease
11:00-1:00 p.m. Where to go from here - led by Drs. Weatherall and Collins

Top of page

Last Reviewed: July 14, 2008
Print Version


See Also:
Conference Participants

Conference Talk Summaries

Working Group Reports

Summary of Meeting Conclusions

Attendee Voting for Research Therapies


PrivacyCopyrightContactAccessibilitySite MapStaff DirectoryFOIAHome Department of Health and Human Services  National Institutes of Health  USA.gov